Mayo Clinic Boosts Digital Pathology with Techcyte Fusion

A healthcare professional reviews digital pathology images on three large monitors while consulting remotely with a colleague via video call, illustrating digital pathology and telemedicine.

Deployment across Mayo Clinic pathology practices integrates AI-enabled digital pathology with historical pathology images and clinical data in a unified workflow.

ROCHESTER, Minn., and OREM, Utah - Mayo Clinic and Techcyte today announced the implementation of Anatomic Pathology (AP) technology, a next-generation digital pathology platform developed through a co-development and intellectual property licensing agreement between the two organizations. This collaboration expands adoption of Mayo Clinic Digital Pathology innovations while advancing development of a next-generation digital pathology platform through a connected artificial intelligence (AI)-driven ecosystem.

Techcyte Fusion AP is a digital pathology solution that unifies whole-slide image (WSI) viewing, case information, workflow tools and AI into a single platform to support anatomic pathology processes. The rollout of Fusion AP builds on a multiyear collaboration between Mayo Clinic and Techcyte to advance digital pathology and laboratory medicine through technologies that support patients, pathologists, laboratories and researchers. Through the agreement, Techcyte has licensed Mayo Clinic-developed intellectual property, enabling the organizations to further develop and broaden access to innovations originating from Mayo Clinic's digital pathology program.

Every advancement in digital pathology is ultimately intended to improve the experience of the patient. Bringing together a patient's pathology images, clinical history and relevant case information into a single, integrated workflow helps pathologists access the information they need more efficiently to support timely, informed diagnostic decisions. For patients, this means pathology teams can spend less time navigating technology and more time focused on delivering the expert, coordinated care that is central to Mayo Clinic's practice.

About Fusion

Fusion is an AI-driven platform shaped by input from Mayo Clinic pathologists and laboratory specialists to support the needs of enterprise anatomic and clinical pathology workflows. The Fusion AP platform streamlines complex pathology operations by bringing together WSI viewing, case information, workflow tools and integrated data sources within a clean, ultrafast, high-performance interface, all on one platform.

"The implementation of Fusion AP, developed through our collaboration with Mayo Clinic, is an important milestone in our shared work to advance digital pathology," says Ben Cahoon, CEO of Techcyte. "Fusion AP brings AI into the pathology workflow in a way that supports efficiency for the pathologists doing the work."

The use of the Fusion AP technology enables enterprise-wide access to over 22.6 million current and historical WSIs, providing pathologists real-time access to Mayo Clinic's archive. Fusion AP is also integrated with Mayo Clinic's electronic health record and Laboratory Information Systems, bringing relevant patient history, lab results, case information and associated WSIs into a single environment to support pathologist review.

"This implementation reflects years of collaboration between our pathology, laboratory and technology teams to co-develop a platform around the way pathologists practice," says Eric Hsi, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester. "By bringing together pathology images, clinical information and AI-enabled tools into a unified digital workflow, we're helping create a more efficient, connected environment that supports high-quality patient care today."

"Mayo Clinic's work in digital pathology is guided by the needs of patients and shaped by the realities of clinical practice," says Jim Rogers, CEO of Mayo Clinic Digital Pathology. "Our collaboration reflects a shared focus on building clinically relevant digital pathology solutions that fit into day-to-day pathology workflows."

Throughout this strategic collaboration, Mayo Clinic and Techcyte will continue to co-develop technologies that enable pathologists to access and deploy AI tools within their existing workflows. The connected ecosystem is intended to support AI applications developed by Techcyte, Mayo Clinic and third-party innovators, creating a flexible framework for advancing diagnostic capabilities across pathology subspecialties.

/Public Release, Courtesy: Mayo Clinic. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.